Menopur

Menotrophin, the active ingredient in Menopur, is a gonadotropin presented as an injectable solution for intramuscular or subcutaneous use. It provides follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) activity to treat infertility caused by anovulation and to support assisted reproductive technologies in women.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Menopur is used in reproductive medicine to stimulate follicular development and ovulation. Infertility due to anovulation: promotes follicle growth and ovulation in women who do not ovulate spontaneously. Controlled ovarian stimulation for assisted reproductive technologies (e.g., IVF): enables multiple follicle development to increase oocyte retrieval. Induction of ovulation in women with hypogonadotropic hypogonadism: supplies necessary FSH/LH activity to trigger ovulation.

Menopur may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Abdominal discomfort or bloating - Injection site pain, redness or swelling - Headache - Nausea or mild vomiting

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (OHSS) with rapid weight gain, ascites or respiratory distress - Thromboembolic events such as deep‑vein thrombosis - Allergic reactions including rash, urticaria or anaphylaxis - Ovarian cyst rupture or hemorrhage

When prescribing Menopur, clinicians should observe several safety measures to minimize risks. - Monitor ovarian response: perform ultrasound and estradiol assessments regularly. - Assess risk of ovarian hyperstimulation syndrome: consider patient history and adjust dose accordingly. - Adjust dose based on individual response: titrate according to follicular growth and hormone levels. - Avoid use during pregnancy: discontinue if pregnancy occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medications that affect hormonal balance or coagulation.

Major Interactions (Avoid): - Concomitant use with other gonadotropin preparations: may markedly increase risk of OHSS. - High‑dose estrogen therapy: can alter ovarian response and increase thrombotic risk. - Anticoagulant drugs (e.g., warfarin, direct oral anticoagulants): heightened bleeding risk if OHSS develops.

Moderate Interactions (Monitor Closely): - GnRH agonists or antagonists used in IVF protocols: may require dose adjustments. - Hormonal contraceptives taken during stimulation cycles: may affect follicular development and require timing changes.